Robotics includes companies involved in the design, creation, and manufacture of robots. These machines can perform tasks autonomously or semi-autonomously, often with the aim of improving efficiency, productivity, and safety across various industries. Robotics companies are rapidly innovating new technology with applications across many industries. They offer opportunities for growth and efficiency, align with long-term automation trends, and have the potential for disruption in emerging markets, making them appealing to investors.
Analysts Offer Insights on Technology Companies: Verint Systems (VRNT), UiPath (PATH) and Uber Technologies (UBER)
Melius Adjusts Price Target on GE Aerospace to $190 From $186
RBC Lowers Price Target on UiPath to $24 From $29, Keeps Sector Perform Rating
Analysts Offer Insights on Healthcare Companies: Axsome Therapeutics (AXSM), Intuitive Surgical (ISRG) and Silence Therapeutics (SLN)
Honeywell International (HON) Receives a Hold From Wells Fargo
Wells Fargo Sticks to Its Hold Rating for UiPath (PATH)
RBC Capital Keeps Their Hold Rating on Medtronic (MDT)
Truist Securities Adjusts Price Target on Medtronic to $88 From $90, Keeps Hold Rating
Analysts Offer Insights on Healthcare Companies: Roche Holding AG (OtherRHHVF), Medtronic (MDT) and Cytokinetics (CYTK)
Goldman Sachs Adjusts Price Target on NVIDIA to $1,200 From $1,100, Keeps Buy Rating
Medtronic Analyst Ratings
Medtronic Poised for Growth: A Buy Rating With Promising Fiscal Projections and Undervalued Stock
Analysts Offer Insights on Healthcare Companies: Medtronic (MDT), Crispr Therapeutics AG (CRSP) and Tango Therapeutics (TNGX)
Analysts Conflicted on These Healthcare Names: MacroGenics (MGNX) and Medtronic (MDT)
Medtronic's Strong Q4 Performance and Positive FY2025 Outlook Merit Buy Rating
Medtronic Q4 Earnings Analysis: Maintaining Hold Rating Amidst Modest Growth Projections and Margin Pressures
Piper Sandler Adjusts Medtronic's Price Target to $85 From $87, Keeps Neutral Rating
Argus Adjusts NVIDIA's Price Target to $1,100 From $950, Keeps Buy Rating
NVIDIA Analyst Ratings
GE Aero Analyst Ratings